| #80 |
Cary P. Moxham |
Triangle Pharmaceuticals |
1 |
| #80 |
Rebecca Sundseth |
Andcare |
1 |
| #80 |
John H. Hebrank |
Embrex |
1 |
| #80 |
Martin J. Maresch |
Akzo Nobel N.V. |
1 |
| #80 |
Stephen Cole |
Microsoft |
1 |
| #80 |
Allen Leonid Roginsky |
IBM |
1 |
| #80 |
Jeffrey Besterman |
Methylgene |
1 |
| #80 |
Courtney Cleophas Eversley |
IBM |
1 |
| #80 |
Elizabeth H. Harris |
Duke University |
1 |
| #80 |
Gregory B. Shriver |
— |
1 |
| #80 |
R. Edward Coleman |
Duke University |
1 |
| #80 |
Awadhesh Mishra |
Jagotec Ag |
1 |
| #80 |
Shuyan Wang |
Duke University |
1 |
| #80 |
Kimberly F. McGowan |
— |
1 |
| #80 |
Laura Captain |
Emory University |
1 |
| #80 |
Luis E. Elizalde |
IBM |
1 |
| #80 |
Harold F. DeHart |
— |
1 |
| #80 |
Chun Yu Liu |
Himax Technologies Limited |
1 |
| #80 |
Robert D. Ross |
Mars, Incorporated |
1 |
| #80 |
William Parker |
E.R. Squibb & Sons. |
1 |
| #80 |
Roger W. Nightingale |
Duke University |
1 |
| #80 |
Miles A. DeForest |
Emc |
1 |
| #80 |
Anton Schindler |
Endoluminal Therapeutics |
1 |
| #80 |
Brent Weston |
North Carolina State University |
1 |
| #80 |
Helga Sonner |
Emc |
1 |
| #80 |
Brian Huber |
Glaxo Wellcome |
1 |
| #80 |
Phillip A. Furman |
Burroughs Wellcome |
1 |
| #80 |
Eric A. Postel |
Duke University |
1 |
| #80 |
Philip Reid Timmons |
— |
1 |
| #80 |
Michael Tolar Martin |
Smithkline Beecham Limited |
1 |
| #80 |
William Taylor |
Taylor Kerr (Couplings) Limited |
1 |
| #80 |
Gennaro A. Cuomo |
IBM |
1 |
| #80 |
Larry W. Burton |
Amt International |
1 |
| #80 |
David Gomez |
X-Celeprint Limited |
1 |
| #80 |
Alexander Suvorov |
Cree |
1 |
| #80 |
Lorrie A. Tomek |
IBM |
1 |
| #80 |
Gina M. Stewart |
Micell Technologies |
1 |
| #80 |
Muntaquim Chowdhury |
Intel |
1 |
| #80 |
P. Krishnan |
AT&T |
1 |
| #80 |
Thurman C. Thorpe |
Biomerieux |
1 |